Skip to main content


Volume 464: debated on Tuesday 16 October 2007

To ask the Secretary of State for Health whether it is his policy that Avastin eye injections should be available on the NHS free of charge to (a) all patients and (b) pensioners who require them; and if he will make a statement. (158724)

Avastin has not been licensed for use in macular degeneration. However, the law allows the use of either unlicensed medicines or the prescribing of a licensed medicinal product “off-label”—that is outside the terms of its marketing authorisation in order to meet special clinical needs. Such prescriptions are subject to the individual clinician’s judgment and are on the personal responsibility of the prescriber, and subject to funding by the primary care trust.